Compounds and compositions for potentiation of tlr agonists
OwnerJondavid DE JONG, Stephanie DEWITTE-ORR +4inventors
InventorsJondavid DE JONG, Stephanie DEWITTE-ORR, Karl Michael KLINGER, Emily MOORE, Sheetij GHOSHAL, Anton KORENEVSKI
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel Toll-like Receptor (TLR) agonist compositions that can demonstrate enhanced innate immune responses, improved stability and lower toxicity than said agonists alone. These immunomodulators comprise one or more TLR agonists linked to glycogen-based nanoparticles. Also provided are processes for manufacturing, and methods of using the compositions to induce therapeutic immune responses.
Claims20
An immunomodulator for enhancing the innate immune response comprising:
- a TLR agonist covalently or non-covalently linked to glycogen-based polysaccharide nanoparticles having a molecular weight of 106 to 107 Da comprising α-D glucose chains, having an average chain length of 11-12, with 1→4 linkage and branching point occurring at 1→6 and with a branching degree of between 6% and 13%.
A method of potentiating a TLR agonist comprising covalently or non-covalently linking the TLR agonist to glycogen-based polysaccharide nanoparticles having a molecular weight of 106 to 107 Da comprising α-D glucose chains having an average chain length of 11-12, with 1→4 linkage and branching point occurring at 1→6 and with a branching degree of between 6% and 13%.
Dependencies are inferred from the claim text.